Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-04

Clinical Trial Update: Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epigallocatechin gallate (green tea extract) on albuminuria in patients with diabetic nephropathy (with hypertension); the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epigallocatechin gallate (Green Tea Extract) (epigallocatechin gallate)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Diabetic Nephropathy, Hypertension | Phase 2 | Status: COMPLETED